Casey, D. & Denny, D. (1977). Pharmacological characterization of tardive dyskinesia. Psychopharmacology 54, 1–8.
Davis, K. & Berger, P. (1978). Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis. Biological Psychiatry 13, 23–49.
Davis, K., Berger, P. & Hollister, L. (1975). Choline for tardive dyskinesia. New England Journal of Medicine 293, 152.
Fann, W. & Lake, C. K. (1974). Cholinergic suppression of tardive dyskinesia. Psychopharmacologia 37, 101–107.
Gerlach, J., Reisby, N. & Randrup, A. (1974). Dopaminergic hyper-sensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia 34, 21–35.
Growdon, J., Hirsch, M. & Wurtman, R. (1977). Oral choline administration to patients with tardive dyskinesia. New England Journal of Medicine 297, 524–527.
Jeste, D. V. & Wyatt, R. J. (1982). Therapeutic strategies against tardive dyskinesia: two decades of experience. Archives of General Psychiatry 39, 803–816.
Kilbinger, H. (1973). Gas chromatographic estimation of acetylcholine in the rabbit heart using a nitrogen selective detector. Journal of Neurochemistry 21, 421–429.
Moore, D. C. & Bowers, M. B. (1980). Identification of a subgroup of tardive dyskinesia patients by pharmacologie probes. American Journal of Psychiatry 137, 1202–1205.
Nasrallah, H. A. (1979). Methodological issues in tardive dyskinesia research. Schizophrenia Bulletin 5, 1–3.
National Institute of Mental Health (1974). Abnormal Involuntary Movement Scale. Public Health Service: Bethesda, MD.
Schooler, N. R. & Kane, J. M. (1982). Research diagnoses for tardive dyskinesia. Archives of General Psychiatry 39, 486–487.
Tamminga, C.Smith, R. & Ericksen, S. (1977). Cholinergic influences in tardive dyskinesia. American Journal of Psychiatry 134, 769–774.
Tarsy, D. & Baldessarini, R. (1976). The tardive dyskinesia syndrome. In Clinical Neuropharmacology, Vol. 1 (ed. Klawans, H. L.), pp. 29–61. Raven Press: New York.
Tarsy, D., Leopold, N. & Sax, D. (1974). Physostigmine in choreiform movement disorder. Neurology 24, 28–33.